LMO2 and acute lymphoblastic leukemia: In conclusion, we investigated a large cohort of homogenously treated adult T-ALL patients and were able to define nine different subgroups with enrichment of the molecular subgroups HOXA and LYL1/LMO2 in adult T-ALL patients.